|Heinz Edgar Lehmann|
July 17, 1911|
|Died||April 7, 1999(aged 87)|
|Notable awards||Order of Canada|
From 1969 to 1972, he was one of the five members of the LeDain Commission, a royal commission appointed in Canada to study the non-medical use of drugs. He was an advocate for decriminalization of marijuana.
He was ahead of his time in that he supported research in the use of the active ingredient psilocybin to alleviate anxiety.
In 1973, he was a member of the Nomenclature Committee of the American Psychiatric Association that decided to drop homosexuality from the Diagnostic and Statistical Manual of Mental Disorders, i.e. to depathologize it.
In 1999, the Canadian College of Neuropsychopharmacology established the Heinz Lehmann Award in his honor, given in recognition of outstanding contributions to research in neuropsychopharmacology in Canada.
- Bayer, R. (1987). Homosexuality and American psychiatry: the politics of diagnosis. Princeton, N.J: Princeton University Press, p. 120 (footnote 41). ISBN 0691028370
- Paris, Joel. "Heinz Lehmann: A Pioneer of Modern Psychiatry". Canadian Psychiatric Association. Archived from the original on September 26, 2006. Retrieved April 26, 2006.
- "Canadian Who's Who 1997 entry". Retrieved April 26, 2006.
|This biography related to medicine in Canada is a stub. You can help Wikipedia by expanding it.|
|This article about a psychiatrist is a stub. You can help Wikipedia by expanding it.|